Intermuscular adipose tissue in patients with systemic lupus erythematosusJorge Luis Gamboa, Daniel Carranza-León, Rachelle Crescenzi, Michael Pridmore, Dungeng Peng, Adriana Marton, Annette Oeser, Cecilia P Chung, Jens Titze, Charles Michael Stein, Michelle Ormseth
22 November 2022
Comparison of short interval and low dose (SILD) with high dose of cyclophosphamide in the susceptibility to infection in SLE: a multicentrereal-world studyMiao Shao, Miao Miao, Xia Zhang, Xiaoying Zhang, Yuan An, Huifang Guo, Lingyan Lei, Qing Zhao, Yanjie Ding, Jin Lin, Rui Wu, Feng Yu, Yucui Li, Huali Miao, Liyun ZhangSee the full list of authors
8 November 2022
CD4 T-cell cooperation promoted pathogenic function of activated naïve B cells of patients with SLEKittikorn Wangriatisak, Piyawan Kochayoo, Pongsakorn Thawornpan, Chaniya Leepiyasakulchai, Thanitta Suangtamai, Pintip Ngamjanyaporn, Ladawan Khowawisetsut, Prasong Khaenam, Prapaporn Pisitkun, Patchanee Chootong
30 September 2022
Role of autoantibodies and blood–brain barrier leakage in cognitive impairment in systemic lupus erythematosusJohn G Hanly, Alexandra Legge, Lyna Kamintsky, Alon Friedman, Javeria A Hashmi, Steven D Beyea, John Fisk, Antonina Omisade, Cynthia Calkin, Tim Bardouille, Chris Bowen, Kara Matheson, Marvin J Fritzler
15 June 2022
Association between systemic lupus erythematosus and disruption of gut microbiota: a meta-analysisShate Xiang, Yiqian Qu, Suhai Qian, Rongyun Wang, Yao Wang, Yibo Jin, Jie Li, Xinghong Ding
28 March 2022
Iberdomide in patients with systemic lupus erythematosus: a randomised, double-blind, placebo-controlled, ascending-dose, phase 2a studyRichard A Furie, Douglas R Hough, Allison Gaudy, Ying Ye, Shimon Korish, Nikolay Delev, Michael Weiswasser, Xiaojiang Zhan, Peter H Schafer, Victoria P Werth
15 February 2022
Reductions in circulating B cell subsets and immunoglobulin G levels with long-term belimumab treatment in patients with SLEHerbert Struemper, Milena Kurtinecz, Lisa Edwards, William W Freimuth, David A Roth, William Stohl
7 February 2022
ANA-positive primary immune thrombocytopaenia: a different clinical entity with increased risk of connective tissue diseasesYuan Liu, Shiju Chen, Guomei Yang, Bin Wang, Jinying Lan, Fan Dai, Peishi Rao, Puqi Wu, Hongyan Qian, Guixiu Shi
5 October 2021
Combining C reactive protein and serum albumin to predict 90-day mortality in systemic lupus erythematosus with serious community-acquired infectionsShuangjun He, Chao Tang, Jie Yu, Jun Ma, Minjie Qiao, Wei Zhou, Yi Chen, Xingyu Zhang
12 July 2021
Impact of systemic lupus erythematosus disease activity, hydroxychloroquine and NSAID on the risk of subsequent organ system damage and death: analysis in a single US medical centreDeanna D Hill, Amanda M Eudy, Peter J Egger, Qinggong Fu, Michelle A Petri
8 April 2021